These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

832 related articles for article (PubMed ID: 24388161)

  • 1. Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study.
    Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Sportouch-Dukhan C; Drouet E; Daubert JC; Linde C;
    Arch Cardiovasc Dis; 2014 Feb; 107(2):112-21. PubMed ID: 24388161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.
    Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Drouet E; Linde C; Daubert C;
    Eur J Heart Fail; 2015 Jul; 17(7):680-8. PubMed ID: 26033771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen study.
    Donal E; Lund LH; Oger E; Reynaud A; Schnell F; Persson H; Drouet E; Linde C; Daubert C;
    Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):106-13. PubMed ID: 26082167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction.
    Lund LH; Donal E; Oger E; Hage C; Persson H; Haugen-Löfman I; Ennezat PV; Sportouch-Dukhan C; Drouet E; Daubert JC; Linde C;
    Eur J Heart Fail; 2014 Sep; 16(9):992-1001. PubMed ID: 25046483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
    van Veldhuisen DJ; Linssen GC; Jaarsma T; van Gilst WH; Hoes AW; Tijssen JG; Paulus WJ; Voors AA; Hillege HL
    J Am Coll Cardiol; 2013 Apr; 61(14):1498-506. PubMed ID: 23500300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure].
    Pokorná V; Jurkovicová O; Kaluzay J; Stecová A; Pont'uch P
    Vnitr Lek; 2010 Aug; 56(8):788-94. PubMed ID: 20845610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study.
    Cleland JG; Taylor J; Freemantle N; Goode KM; Rigby AS; Tendera M
    Eur J Heart Fail; 2012 May; 14(5):487-94. PubMed ID: 22505395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure.
    Juillière Y; Suty-Selton C; Riant E; Darracq JP; Dellinger A; Labarre JP; Druelle J; Mulak G; Danchin N; Jourdain P;
    Arch Cardiovasc Dis; 2014 Jan; 107(1):21-32. PubMed ID: 24388162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of structural heart disease and diastolic dysfunction in heart failure with preserved ejection fraction assessed according to the ESC guidelines - A substudy in the Ka (Karolinska) Ren (Rennes) study.
    Persson H; Donal E; Lund LH; Matan D; Oger E; Hage C; Daubert JC; Linde C;
    Int J Cardiol; 2019 Jan; 274():202-207. PubMed ID: 30049496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
    N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
    Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
    Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction.
    Gori M; Lam CS; Gupta DK; Santos AB; Cheng S; Shah AM; Claggett B; Zile MR; Kraigher-Krainer E; Pieske B; Voors AA; Packer M; Bransford T; Lefkowitz M; McMurray JJ; Solomon SD;
    Eur J Heart Fail; 2014 May; 16(5):535-42. PubMed ID: 24574260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.
    Nolte K; Herrmann-Lingen C; Platschek L; Holzendorf V; Pilz S; Tomaschitz A; Düngen HD; Angermann CE; Hasenfuß G; Pieske B; Wachter R; Edelmann F
    ESC Heart Fail; 2019 Apr; 6(2):262-270. PubMed ID: 30784226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of NT-proBNP, 3D LA volume and LV dyssynchrony in patients with acute STEMI undergoing primary percutaneous intervention.
    Siva Sankara C; Rajasekhar D; Vanajakshamma V; Praveen Kumar BS; Vamsidhar A
    Indian Heart J; 2015; 67(4):318-27. PubMed ID: 26304563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.